À±°æÈ£			 ¸íÀÇ

½É±Ù°æ»öÁõ Ä¡·áÀÇ ÃÖÀü¼±À» ÁöŰ´Â »ý¸í ÁöÅ´ÀÌ

À±°æÈ£ ¸íÀÇ

  • ¼Ò ¼Ó
    ¿ø±¤´ëÇб³º´¿ø ¼øÈ¯±â³»°ú,½ÉÇ÷°ü³»°ú
  • Àü¹®ºÐ¾ß
    ½É±Ù°æ»öÁõ, Çù½ÉÁõ, Ç÷°üÁßÀç½Ã¼ú

ÁÖ¿ä Áø·á ºÐ¾ß´Â ½É±Ù°æ»öÁõ, Çù½ÉÁõ, Ç÷°üÁßÀç½Ã¼úÀÌ´Ù. ¡®½ÉÇ÷°üÁúȯÀÇ ¿øÃµÀ» ¸·ÀÚ¡¯´Â ¸ñÇ¥·Î µ¿¸Æ°æÈ­¿Í ½ÉÇ÷°üÁúȯÀ» ¿¹¹æÇÏ°í ¾ïÁ¦ÇÏ´Â È¿°ú¿¡ ´ëÇÑ ¿¬±¸¸¦ ²ÙÁØÈ÷ ÁøÇàÇϰí ÀÖ´Ù. ȯÀÚ¿¡°Ô Ä£ÀýÇÏ°í ²Ä²ÄÇÏ°Ô ¼³¸íÇØ Áִ ģÀýÇÑ ÀÇ»ç·Î Áö¿ª¿¡ À̸§ÀÌ ³ª ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • ¿ø±¤´ë ÀÇ´ë Çлç
  • ¿ø±¤´ë ÀÇ´ë ¼®»ç
  • Àü³²´ë ÀÇ´ë ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) ¿ø±¤´ëÇб³º´¿ø ±Ç¿ª½É³úÇ÷°üÁúȯ¼¾ÅÍÀå
  • ¿ø±¤´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿øÀå
  • Àü³²´ëº´¿ø ¼øÈ¯±â³»°ú ÀüÀÓÀÇ

¼ö»ó³»¿ª

Awards List
  • ÀÇ»ý¸í¿¬±¸¿ø ÀÓ»óÀÇÇבּ¸¼Ò'2022Çг⵵ ÀÓ»ó±³¼ö ¿ì¼ö¿¬±¸ÀÚ' ¼±Á¤ (2023)
  • º¸°Çº¹ÁöºÎÀå°ü ǥâÀå ¼ö»ó (2022)
  • ÀÓ»ó±³¼ö ¿ì¼ö¿¬±¸ÀÚ ¼±Á¤ (2022)
  • ¿ø±¤´ëÇб³ ÃÑÀå °ø·Î»ó (2017)
  • Çѱ¸°úÇбâ¼ú´ÜüÃÑ¿¬ÇÕȸ (2015)
  • Á¦25ȸ °úÇбâ¼ú ¿ì¼ö³í¹®»ó (2015)

ÇÐȸȰµ¿

Academic activities
  • ´ëÇѽÉÀåÇÐȸ Á¤È¸¿ø ¹× ¼øÈ¯±â³»°ú ºÐ°ú Àü¹®ÀÇ
  • Çѱ¹ÁöÁúµ¿¸Æ°æÈ­ÇÐȸ Á¤È¸¿ø
  • ´ëÇѳ»°úÇÐȸ Á¤È¸¿ø
  • ´ëÇѽÉÀåÇÐȸ È«º¸À§¿ø
  • ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ °£ÇàÀ§¿ø
½É±Ù°æ»öÁõ
´ëÇ¥¼­Àû

½É±Ù°æ»öÁõ

  • ÀúÀÚ(±Û)´ëÇѽÉÀåÇÐȸ
  • ÃâÆÇ»ç´ëÇÑÀÇÇÐ
  • ¹ßÇàÀÏ2022³â 9¿ù 2ÀÏ
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 3°Ç
Á¦ ¸ñ ½ÉÇ÷°üÁßÀç¸Å´º¾ó
ÃâÆÇ»ç ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ ¹ßÇàÀÏ 2022.5.16.
Á¦ ¸ñ Ç×Ç÷ÀüÁ¦ »ç¿ë ¾È³»¼­
ÃâÆÇ»ç ´ëÇÑÀÇÇÐ ¹ßÇàÀÏ 2024.1.11.
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Clinical Benefit of Intravascular Imaging Compared With Conventional Angiography in Left Main Coronary Artery Intervention/±³½ÅÀúÀÚ
¹ßÇ¥³âµµ 2023.11. ¹ßÇ¥Áö Circulation Cardiovascular Intervention
Á¦ ¸ñ Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention The SMART-CHOICE Randomized Clinical Trial / °øµ¿(Âü¿©)
¹ßÇ¥³âµµ 2019.06 ¹ßÇ¥Áö JAMA / American Medical Association
Á¦ ¸ñ Results of a 10-Year Experience in Korea Using Drug-Eluting Stents During Percutaneous Coronary Intervention for Acute Myocardial Infarction (from the Korea Acute Myocardial Infarction Registry) / °øµ¿(Âü¿©)
¹ßÇ¥³âµµ 2018.08 ¹ßÇ¥Áö AMERICAN JOURNAL OF CARDIOLOGY / EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
Á¦ ¸ñ High-intensity Statin Treatments in Clinically Stable Patients on Aspirin Monotherapy 12 Months After Drug-eluting Stent Implantation: A Randomized Study / °øµ¿(Âü¿©)
¹ßÇ¥³âµµ 2018.06 ¹ßÇ¥Áö REVISTA ESPANOLA DE CARDIOLOGIA / EDICIONES DOYMA S A
Á¦ ¸ñ Safety and Efficacy of the Endeavor Resolute?? Stent in Patients with Multivessel Disease: The HEART (Honam EndeAvor ResoluTe) Prospective, Multicenter Trial. / °øµ¿(Âü¿©)
¹ßÇ¥³âµµ 2018.01 ¹ßÇ¥Áö CMJ / Chonnam medical journal
Á¦ ¸ñ Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month DAPT trial/Á¦1ÀúÀÚ
¹ßÇ¥³âµµ 2022.8.19. ¹ßÇ¥Áö Eurointervention
Á¦ ¸ñ Factors Related to Major Bleeding After Ticagrelor Therapy: Results from the TICO Trial/±³½ÅÀúÀÚ
¹ßÇ¥³âµµ 2021.4.6. ¹ßÇ¥Áö Journal of American Heart Association

¸íÀÇqna ¸íÀÇ QnA

Q °¡Àå °ü½É ÀÖ´Â ºÐ¾ß¿Í ¾÷ÀûÀÌ ÀÖ´Ù¸é ¾Ë·ÁÁÖ¼¼¿ä

½É±Ù°æ»öÁõÀÇ Á÷Á¢ÀûÀÎ ¿øÀÎÀº Ç÷Àü°ú Ç÷°ü¿°ÁõÀÔ´Ï´Ù. À̸¦ ¿¹¹æÇϰí Ä¡·áÇϱâ À§ÇÑ ¿©·¯ ¾à¹° ¹× ½ºÅÙÆ® ¿¬±¸¸¦ ÁÖ·ÎÇϰí ÀÖ½À´Ï´Ù.

Q ȯÀÚ Áø·á¿¡ ÀÖ¾î °¡Àå Áß¿äÇÏ°Ô »ý°¢ÇÏ´Â °¡Ä¡´Â?

°Ë»ç °á°ú¸¦ °íÄ¡´Â Àǻ簡 ¾Æ´Ñ ȯÀÚ¸¦ °íÄ¡´Â Àǻ簡 µÇ·Á°í ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.

Q ȯÀڵ鿡°Ô ÀüÇÏ°í ½ÍÀº ¸»¾¸

¹«ºÐº°ÇÏ°í ¹æ´ëÇØÁø ÀÇ·á»ó½Ä, ³Ê¹« Áö³ªÄ£ °Ç°­°ËÁø °á°úµé¿¡ ÇöȤµÇÁö ¸»°í ÀÇ·áÁøÀ» ¹Ï°í ³ë·ÂÇÑ´Ù¸é ÁÁÀº °á°ú°¡ ÀÖÀ» °ÍÀÔ´Ï´Ù.

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

¿ø±¤´ëÇб³º´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1577-3773
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

¿ø±¤´ëÇб³º´¿øÀº Ä¡·áÀÇ ÀûÁ¤¼º°ú ÀÇ·áÀÇ Áú Æò°¡¿¡¼­ ÃÖ°í µî±ÞÀ» ȹµæÇÏ´Â ÀüºÏ±Ç¿ª ³» ÃÖ»óÀ§ ÀÇ·á±â°üÀ¸·Î¼­ ÁßÁõȯÀÚ Äɾî¿Í ÀÀ±ÞȯÀÚÀÇ °ñµçŸÀÓÀ» ÁöŰ´Â ±¹³» À¯ÀÏÀÇ Çí»ç°ï ÀÀ±ÞÀÇ·áü°è¸¦ °®Ãß°í, 39°³ Áø·á°ú¿Í 16°³ Àü¹®¼¾ÅÍ, ÃֽŠÀåºñ¸¦ °®Ãß°í ´Ù¾çÇØÁö´Â ÀηùÀÇ Áúº´¿¡ ÃÖÀûÀÇ ÀÇ·á¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, Àü±¹ »ç¸³´ëº´¿ø Áß À¯ÀÏÇÏ°Ô ÀüºÏ °ø°øº¸°ÇÀÇ·áÁö¿ø´ÜÀ» À§Å¹ ¿î¿µÇϸç, ÀÍ»ê±Ç Ã¥ÀÓÀÇ·á±â°üÀ¸·Î Áö¿ª¿Ï°áÇü °ø°øÀÇ·á±â°ü ¿ªÇÒÀ» ¼öÇàÇÕ´Ï´Ù.

¿ø±¤´ëÇб³º´¿ø		 À̹ÌÁö

Àü¶óºÏµµ ÀÍ»ê½Ã ¹«¿Õ·Î 895

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä

°°Àº ºÐ¾ß ¸íÀÇ °°Àº ºÐ¾ß ¸íÀÇ

¸íÀÇ ´õº¸±â ´õº¸±â